跳至主要内容
临床试验/EUCTR2015-002965-43-IT
EUCTR2015-002965-43-IT进行中(未招募)1 期

Dopaminergic therapy for Alzheimer's disease patients - NA

I.R.C.C.S. FONDAZIONE S.LUCIA0 个研究点目标入组 130 人开始时间: 2018年2月2日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
130

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • All AD patients will have to show a moderate level of dementia, as assessed by a neuropsychological evaluation including the MMSE (ranging from 18 to 24) and a standardized neuropsychological battery (Carlesimo et al,1996) according to criteria NINCDS-ADRDA
  • Are the trial subjects under 18? no
  • Number of subjects for this age range: 1
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 20
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 120

排除标准

  • Subjects with CSF values of Aß1-42 >550 pg/mL will not be included. Subjects will be excluded if they have either two or more hyperintense lesions with a diameter = 10mm or more than eight hyperintense lesions with a diameter between 5 and 9 mm on dual-echo MR images

研究者

发起方
I.R.C.C.S. FONDAZIONE S.LUCIA

相似试验